Rajiv Chhabra, MD, James H

Slides:

Advertisements

Similar presentations

Diverticulosis and Diverticulitis

Advertisements

25-Year Physical Activity Trajectories and Development of Subclinical Coronary Artery Disease as Measured by Coronary Artery Calcium: The Coronary Artery.

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Pleomorphic Adenoma in the Parotid Gland

Lipoprotein(a), Cardiovascular Disease, and Contemporary Management

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease.

Long-term Medical Management of the Liver Transplant Recipient: What the Primary Care Physician Needs to Know Siddharth Singh, MD, Kymberly D. Watt,

Ductal Carcinoma in Situ of the Breast

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention Erin D. Michos, MD, MHS, Michael J. Blaha,

A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease.

The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity Research and the Scientific Formulation of National Dietary.

Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies Arthur R. Menezes, MD, Carl J. Lavie,

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Diverticulosis and Diverticulitis

Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease Connie M. Rhee, MD, MSc, Kamyar Kalantar-Zadeh, MD, MPH, PhD, Vanessa Ravel,

Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J

A 57-kg Tumor Mayo Clinic Proceedings

Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults Tomohide Yamada, MD, PhD, Shintaro Yanagimoto,

Charles R. Harper, MD, Terry A. Jacobson, MD Mayo Clinic Proceedings

Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults Tomohide Yamada, MD, PhD, Shintaro Yanagimoto,

Can Vitamin D Deficiency Break Your Heart?

Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story

Calcium Embolus to the Brain

Gestational Trophoblastic Disease

Topical Analgesics in the Management of Acute and Chronic Pain

Standing, Obesity, and Metabolic Syndrome

The Melanoma Epidemic Thus Far

Acupuncture Mayo Clinic Proceedings

Coronary Artery Disease: A Continuum, Not a Threshold

James H. O'Keefe, M.D., Carl J. Lavie, M.D., Ben D. McCallister, M.D.

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Contemporary Evidence-Based Guidelines

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Pancreatic Ductal Adenocarcinoma

Barbara P. Yawn, MD, MSc, MSPH, MeiLan K. Han, MD, MS

Lipid Profiles in Out-of-Hospital Sudden Unexpected Death

Effects of Statins on Renal Function

Maximal Estimated Cardiorespiratory Fitness, Cardiometabolic Risk Factors, and Metabolic Syndrome in the Aerobics Center Longitudinal Study Conrad P.

Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,

Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention Abdallah Al-Salameh, MD, Philippe Chanson,

Pharmacogenomics: Precision Medicine and Drug Response

Classic Hodgkin Lymphoma

Aspiration Pneumonia and Related Syndromes

Sophie K. Kieffer, Nina Zisko, PhD, Jeff S

Scott I. Kahan, MD, MPH Mayo Clinic Proceedings

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Pleomorphic Adenoma in the Parotid Gland

Renal Pyelocalyceal Squamous Cell Carcinoma

Evaluation and Management of Penicillin Allergy

Evaluating the Patient With Diarrhea: A Case-Based Approach

Institutional Review Boards: What Clinician Researchers Need to Know

Diabetic Mastopathy Mayo Clinic Proceedings

Rhanderson Cardoso, MD, Roger S

Hepatocellular Carcinoma

Down River by Charles Munch

Postoperative Trouble

71-Year-Old Man With Syncope and Chronic Leg Edema

Foreign Body Impaction in the Esophagus

Medical Treatment of Overactive Bladder: In Response

Lowering the High Cost of Cancer Drugs—IV

Mantle Cell Involvement of the Spleen

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

Squamous Cell Carcinoma of the Tongue

Is There an “Asymptote of Gain” Beyond Which Further Increases in Cardiorespiratory Fitness Convey No Additional Benefits on Mortality and Atrial Fibrillation?

The Obesity Paradox: Perception vs Knowledge

Cindy A. Kermott, MD, MPH, Darrell R. Schroeder, MS, Stephen L

Diagnosis and Management of Headache in Older Adults

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

Presentation transcript:

Association of Coronary Artery Calcification With Hepatic Steatosis in Asymptomatic Individuals Rajiv Chhabra, MD, James H. O’Keefe, MD, Harshal Patil, MD, Evan O’Keefe, Randall C. Thompson, MD, Shaya Ansari, MD, Kevin F. Kennedy, MS, Linda W. Lee, MD, John H. Helzberg, MD Mayo Clinic Proceedings Volume 88, Issue 11, Pages 1259-1265 (November 2013) DOI: 10.1016/j.mayocp.2013.06.025 Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 1 Odds ratios of age, sex, traditional Framingham risk factors, metabolic syndrome, and hepatic steatosis with coronary artery disease. Coronary artery disease was defined by a coronary calcium score of 100 Agatston units or higher on noncontrast computed tomography screening. LDL-C = low-density lipoprotein cholesterol. Mayo Clinic Proceedings 2013 88, 1259-1265DOI: (10.1016/j.mayocp.2013.06.025) Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 2 Odds ratios of coronary artery disease, age, dyslipidemia, diabetes, metabolic syndrome, and body mass index (BMI) with hepatic steatosis. Hepatic steatosis was defined by liver density that was 10 or more Hounsfield units less than splenic density. LDL-C = low-density lipoprotein cholesterol. Mayo Clinic Proceedings 2013 88, 1259-1265DOI: (10.1016/j.mayocp.2013.06.025) Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions